Skip to main content
Livermore
Livermore
ZHEN

Passage BIO, Inc.

PASG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001787297

No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.

13F holders, Q3 2023

Institutional positions in Passage BIO, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
−4 vs. Q2 2023
Shares held
32.4M
−978.2K (−2.9%) vs. Q2 2023
Total value
$21.3M
−$10.1M (−32.1%) vs. Q2 2023
New holders
2
14 more added
Sold out
6
13 more reduced

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 51 institutions
Q1 2021: 90 institutionsQ2 2021: 102 institutionsQ3 2021: 103 institutionsQ4 2021: 102 institutionsQ1 2022: 110 institutionsQ2 2022: 87 institutionsQ3 2022: 76 institutionsQ4 2022: 68 institutionsQ1 2023: 59 institutionsQ2 2023: 56 institutionsQ3 2023: 51 institutionsQ4 2023: 52 institutionsQ1 2024: 51 institutionsQ2 2024: 45 institutionsQ3 2024: 45 institutionsQ4 2024: 46 institutionsQ1 2025: 42 institutionsQ2 2025: 41 institutionsQ3 2025: 32 institutionsQ4 2025: 30 institutionsQ1 2026: 35 institutionsQ2 2026: 29 institutions
Value heldQ3 2023: $21.3M
Q1 2021: $786.5MQ2 2021: $558.8MQ3 2021: $419.1MQ4 2021: $277.7MQ1 2022: $133.2MQ2 2022: $99.6MQ3 2022: $49.3MQ4 2022: $51.6MQ1 2023: $34.0MQ2 2023: $31.4MQ3 2023: $21.3MQ4 2023: $33.1MQ1 2024: $54.4MQ2 2024: $32.0MQ3 2024: $27.1MQ4 2024: $21.6MQ1 2025: $12.8MQ2 2025: $13.0MQ3 2025: $13.2MQ4 2025: $18.6MQ1 2026: $13.8MQ2 2026: $6.82M
Institutions holding PASG and their total value by quarter
QuarterHoldersValue
Q2 202629$6.82M
Q1 202635$13.8M
Q4 202530$18.6M
Q3 202532$13.2M
Q2 202541$13.0M
Q1 202542$12.8M
Q4 202446$21.6M
Q3 202445$27.1M
Q2 202445$32.0M
Q1 202451$54.4M
Q4 202352$33.1M
Q3 202351$21.3M
Q2 202356$31.4M
Q1 202359$34.0M
Q4 202268$51.6M
Q3 202276$49.3M
Q2 202287$99.6M
Q1 2022110$133.2M
Q4 2021102$277.7M
Q3 2021103$419.1M
Q2 2021102$558.8M
Q1 202190$786.5M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q2 2023.

Institutions holding PASG in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Royal Bank of Canada40$00.00%−618−93.9%Reduced
CWM, LLC5$00.00%00.0%Unchanged
Bank of America Corp1$10.00%00.0%Unchanged
Qube Research & Technologies Ltd4$30.00%+4New
Group One Trading, L.P.47$310.00%00.0%Unchanged
Advisor Group Holdings, Inc.276$1820.00%+59+27.2%Added
Wells Fargo & Company288$1900.00%+44+18.0%Added
US Bancorp500$3290.00%00.0%Unchanged
Federated Hermes, Inc.511$3360.00%−1,141−69.1%Reduced
Rhumbline Advisers783$5150.00%00.0%Unchanged
Steward Partners Investment Advisory, LLC1,010$6650.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec8,010$5.27K0.00%+10+0.1%Added
JPMorgan Chase & Co9,385$6.17K0.00%+8,116+639.6%Added
D. E. Shaw & Co., Inc.10,026$6.60K0.00%−124,264−92.5%Reduced
Barclays PLC13,153$8.65K0.00%00.0%Unchanged
Bank of New York Mellon Corp13,647$8.98K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)13,725$9.03K0.00%+11,154+433.8%Added
HighTower Advisors, LLC20,435$12.0K0.00%−18,888−48.0%Reduced
XTX Topco Ltd21,424$14.1K0.00%+21,424New
Cresset Asset Management, LLC23,725$15.6K0.00%00.0%Unchanged
Goldman Sachs Group Inc27,449$18.1K0.00%−70−0.3%Reduced
Northern Trust Corp53,113$34.9K0.00%−5,000−8.6%Reduced
FMR LLC62,021$40.8K0.00%00.0%Unchanged
Squarepoint Ops LLC74,046$48.7K0.00%+4,334+6.2%Added
Marquette Asset Management, LLC86,050$56.6K0.01%00.0%Unchanged
Pale Fire Capital SE98,662$64.9K0.01%00.0%Unchanged
Citadel Advisors LLC103,499$68.1K0.00%+17,051+19.7%Added
Fiduciary Trust Co115,000$75.7K0.00%00.0%Unchanged
Millennium Management LLC116,416$76.6K0.00%−91,047−43.9%Reduced
State Street Corp123,873$81.5K0.00%00.0%Unchanged
RBF Capital, LLC142,807$94.0K0.01%00.0%Unchanged
Morgan Stanley176,920$116.4K0.00%+65,719+59.1%Added
Lynx1 Capital Management LP190,124$125.1K0.08%−977,219−83.7%Reduced
Two Sigma Investments, LP228,254$150.2K0.00%−31,600−12.2%Reduced
Two Sigma Advisers, LP240,200$158.1K0.00%−7,500−3.0%Reduced
Geode Capital Management, LLC332,203$218.7K0.00%+289+0.1%Added
Weiss Multi-Strategy Advisers LLC367,696$242.0K0.01%00.0%Unchanged
Tang Capital Management LLC400,000$263.2K0.04%+100,000+33.3%Added
Acuitas Investments, LLC418,161$275.1K0.16%−120.0%Reduced
Bridgeway Capital Management, LLC506,600$333.3K0.01%+117,000+30.0%Added
Acadian Asset Management LLC604,678$396.0K0.00%+25,872+4.5%Added
Renaissance Technologies LLC994,399$654.0K0.00%+15,304+1.6%Added
BlackRock Inc.1,012,324$666.1K0.00%−42,898−4.1%Reduced
Frazier Life Sciences Management, L.P.1,758,219$1.16M0.08%−91,781−5.0%Reduced
Vanguard Group Inc2,017,883$1.33M0.00%00.0%Unchanged
BML Capital Management, LLC2,058,767$1.35M1.25%00.0%Unchanged
Erste Asset Management GmbH2,360,800$1.55M0.03%+200,000+9.3%Added
New Leaf Venture Partners, L.L.C.2,497,922$1.65M2.12%00.0%Unchanged
Versant Venture Management, LLC4,959,769$3.26M1.73%00.0%Unchanged
OrbiMed Advisors LLC10,124,576$6.66M0.15%00.0%Unchanged
TSFG, LLC100––00.0%Unchanged
Annandale Capital, LLC0$00.00%−54,338−100.0%Sold out
Cornercap Investment Counsel Inc0$00.00%−49,767−100.0%Sold out
Deutsche Bank AG0$00.00%−24,697−100.0%Sold out
Veritable, L.P.0$00.00%−23,045−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−20,608−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−75−100.0%Sold out
First Capital Advisors Group, LLC.––––Not filed